Evaluation Oncotype DX® 21-Gene Recurrence Score and clinicopathological parameters in early stage breast cancer

被引：0
|
作者：
Lashen, A. L. [1 ]
Toss, M. T. [1 ]
Fadhil, W. F. [1 ]
Oni, G. O. [1 ]
Madhusudan, S. M. [1 ]
Rakha, E. R. [1 ]
机构：
[1] Univ Nottingham, Nottingham, England
来源：
JOURNAL OF PATHOLOGY | 2023年 / 261卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P6
引用
收藏
页码：S10 / S10
页数：1
相关论文
共 50 条
  • [21] Decision impact of the 21-Gene Oncotype DX Recurrence Score Assay® in the Czech Republic on recommendations for adjuvant chemotherapy in estrogen receptor positive early stage breast cancer (ESBC) patients
    Petrakova, K.
    Petruzelka, L.
    Holanek, M.
    Svoboda, T.
    Benesova, V.
    Palacova, M.
    Kolarova, I.
    Bielcikova, Z.
    Chrapava, M.
    BREAST, 2019, 44 : S16 - S16
  • [22] The 21-Gene Recurrence Score in Male Breast Cancer
    Gulisa Turashvili
    Monica Gonzalez-Loperena
    Edi Brogi
    Maura Dickler
    Larry Norton
    Monica Morrow
    Hannah Y. Wen
    Annals of Surgical Oncology, 2018, 25 : 1530 - 1535
  • [23] Association of 21-gene recurrence score and locoregional recurrence in early breast cancer patients
    Zeng, Yufei
    Gao, Weiqi
    Chen, Xiaosong
    Shen, Kunwei
    CANCER BIOMARKERS, 2022, 35 (01) : 111 - 118
  • [24] The 21-Gene Recurrence Score in Male Breast Cancer
    Turashvili, Gulisa
    Gonzalez-Loperena, Monica
    Brogi, Edi
    Dickler, Maura
    Norton, Larry
    Morrow, Monica
    Wen, Hannah Y.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (06) : 1530 - 1535
  • [25] Impact of Oncotype DX Recurrence Score on Breast Cancer Prognostic Stage Group
    Breaux, Andrea C.
    Sanders, Mary Ann
    Turner, Bradley M.
    Wu, Xiaoyong
    Rai, Shesh N.
    Riley, Elizabeth C.
    MODERN PATHOLOGY, 2018, 31 : 52 - 52
  • [26] Impact of Oncotype DX Recurrence Score on Breast Cancer Prognostic Stage Group
    Breaux, Andrea C.
    Sanders, Mary Ann
    Turner, Bradley M.
    Wu, Xiaoyong
    Rai, Shesh N.
    Riley, Elizabeth C.
    LABORATORY INVESTIGATION, 2018, 98 : 52 - 52
  • [27] Oncotype DX Breast Recurrence Score(R): A Review of its Use in Early-Stage Breast Cancer
    Syed, Yahiya Y.
    MOLECULAR DIAGNOSIS & THERAPY, 2020, 24 (05) : 621 - 632
  • [28] Economic impact of 21-gene recurrence score testing on early-stage breast cancer in Ireland
    Smyth, Lillian
    Watson, Geoff
    Walsh, Elaine M.
    Kelly, Catherine M.
    Keane, Maccon
    Kennedy, M. John
    Grogan, Liam
    Hennessy, Bryan T.
    O'Reilly, Seamus
    Coate, Linda E.
    O'Connor, Miriam
    Quinn, Cecily
    Verleger, Katharina
    Schoeman, Olaf
    O'Reilly, Susan
    Walshe, Janice M.
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 153 (03) : 573 - 582
  • [29] COST-BENEFIT ANALYSIS OF A 21-GENE RECURRENCE SCORE FOR EARLY STAGE BREAST CANCER IN SINGAPORE
    de Lima, Lopes G.
    Chien, R.
    Hornberger, J.
    VALUE IN HEALTH, 2010, 13 (07) : A512 - A512
  • [30] Effect of 21-gene recurrence score in decision-making for surgery in early stage breast cancer
    Wu, San-Gang
    Zhang, Wen-Wen
    Wang, Jun
    Dong, Yong
    Chen, Yong-Xiong
    He, Zhen-Yu
    ONCOTARGETS AND THERAPY, 2019, 12 : 2071 - 2078
12345